EORTC-NCI-AACR - 18th Symposium - Molecular Targets and Cancer Therapeutics. New approaches in treating cancer.

摘要

In opening the 18th Symposium on Molecular Targets and Cancer Therapeutics, organizers from the European Organisation for Research and Treatment of Cancer (EORTC, the US National Cancer Institute (NCI) and the American Association for Cancer Research (AACR) highlighted many current exciting changes in cancer drug development. Commenting on the numerous new drug developments and initiatives in oncology, conference chairman Alexander Eggermont (Erasmus University Rotterdam, the Netherlands) noted that science drives the network for drug discovery, and multiple sessions on new drug targets at the conference emphasized the crucial role of molecular biology and other fundamental research. Furthermore, the innovative nature of targeted therapy exemplified the global interaction between academia, industry and government, the results of which may ultimately lead to extraordinary benefits for patients.